Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 3

Sponsor Class

OTHER 223INDUSTRY 58NIH 43OTHER_GOV 23NETWORK 7UNKNOWN 3INDIV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 58Breast 49Thoracic 25Head & Neck 13Lymphoid 12CNS 6Other hematologic neoplasm 5Gynecologic 5Tumor-Agnostic 3Sarcoma 3Other solid neoplasm 2Genitourinary 2Other neoplasm 1NET 1Myeloid 1Endocrine 1

Conditions

Sarcoma 2Leiomyosarcoma 1

Interventions

endostar protein 1camrelizumab 1apatinib 1Temozolomide 1Gemcitabine 1Epirubicin 1Endostatins 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Sarcoma × Clear all
NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

ChineseAMS

Phase NA Unknown
28 enrolled
Sarcoma

Leiomyosarcoma

NCT04447274 2020-06-25

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

ChineseAMS

Phase 2 Unknown
20 enrolled
Sarcoma

Sarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡